The discovery of angiogenic factors: A historical review

General Pharmacology: Vascular System

Volumn 35, Issue 5, 2000, Pages 227-231

  Ribatti, Domenico ^a   Vacca, Angelo ^b   Presta, Marco ^c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Angiogenesis; Angiogenic factors; Cytokines; History of medicine

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BIOLOGY; CAPILLARY; CONFERENCE PAPER; HISTORY; HUMAN; MEDICAL LITERATURE; NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTORS; HISTORY, 20TH CENTURY; HUMANS; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034581635     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(01)00112-4     Document Type: Conference Paper

References (45)

1. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
2. Biological roles of fibroblast growth factor-2
3. Isolation and partial molecular characterization of pituitary fibroblast growth factor
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor
6. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
7. Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
8. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF
9. Nucleoside requirements for the in vivo growth of bovine aortic endothelial cells
10. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
11. Antiangiogenesis agents
12. Isolation of a tumor fraction responsible for angiogenesis
13. Isolation of brain fibroblast growth factor by heparin-sepharose affinity chromatography: Identity with pituitary fibroblast growth factor
14. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells
15. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on bovine capillary endothelial cells within collagen gels
16. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
17. Review of preclinical and clinical results with vascular endothelial growth factors for therapeutic angiogenesis
18. Vessel cooption, regression and growth in tumors mediated by angiopoietins and VEGF
19. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
20. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
21. Vascular permeability factor, an endothelial cell mitogen related to platelet-derived growth factor
22. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
23. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
24. Vascular endothelial growth factor is a secreted angiogenic mitogen
25. An endothelial cell growth factor from the mouse neuroblastoma cell line NB41
26. Heparin binds endothelial cell growth factor, the principal cell mitogen in bovine brain
27. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
28. Endothelium stimulating factor from Walker carcinoma cells. Relation to tumor angiogenic factor
29. Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration
30. In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase
31. Manipulating angiogenesis: From basic science to the bedside
32. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro
33. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells
34. Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and DNA migration
35. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders
36. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluids
37. Vascular permeability factor, tumor angiogenesis and stroma generation
38. Heparin-affinity: Purification of a tumor-derived capillary endothelial cell growth factor
39. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor
40. Cell-type specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
41. Requisite role of Angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
42. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
43. Isolation of the nonhistone proteins of rat Walker 256 carcinoma. Their association with tumor angiogenesis
44. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
45. An angiogenic factor isolated from tumours: A potent low-molecular weight compound